[1]陈付文,郑春生,黄柿兵,等.肝动脉化疗栓塞联合射频消融治疗大肝癌的临床观察[J].介入放射学杂志,2015,(08):684-687.
 CHEN Fu- wen,ZHENG Chun- sheng,HUANG Shi- bing,et al.TACE combined with RFA for the treatment of massive primary hepatocellular carcinomas: observation of clinical efficacy and safety[J].journal interventional radiology,2015,(08):684-687.
点击复制

肝动脉化疗栓塞联合射频消融治疗大肝癌的临床观察 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2015年08期
页码:
684-687
栏目:
肿瘤介入
出版日期:
2015-08-25

文章信息/Info

Title:
TACE combined with RFA for the treatment of massive primary hepatocellular carcinomas: observation of clinical efficacy and safety
作者:
陈付文 郑春生 黄柿兵 杨龙林 刘建平 施长生
Author(s):
CHEN Fu- wen ZHENG Chun- sheng HUANG Shi- bing YANG Long- lin LIU Jian- ping SHI Chang- sheng
Interventional Ward, Department of Medical Imaging, Anqing Municipal Petrochemical Hospital, Anqing, Anhui province 246000, China
关键词:
【关键词】 肝癌 肝动脉化疗栓塞 射频消融 介入
文献标志码:
A
摘要:
【摘要】 目的 探讨肝动脉化疗栓塞(TACE)联合射频消融(RFA)治疗大肝癌的疗效及安全性。方法 分析2011年3月—2014年6月23例大肝癌患者先行TACE治疗1~2次,再序贯RFA治疗,并随访其术后临床症状、甲胎蛋白(AFP)、肝功能及影像学改变情况等。结果 23例患者治疗后临床症状均有缓解,一般状况改善;所有患者AFP均明显下降,差异有统计学意义(t=2.48,P=0.002);影像检查见病灶体积有所缩小,病灶内有不同程度的碘油沉积,并可见片状坏死区,增强后无明显强化;显效、有效、无效率分别为43.5%、52.2%、4.3%。随访4~22个月,中位生存时间为9.6个月,半年和1年的生存率分别为86.9%和43.4%。结论 TACE联合RFA治疗大肝癌疗效确切,值得临床推广应用。

参考文献/References:

[参 考 文 献]

[1] 常中飞, 王茂强, 刘凤永, 等. 综合治疗巨大肝癌的临床疗效及预后因素分析[J]. 中华肿瘤杂志, 2014, 36: 59- 62.
[2] 代向党, 王 赢, 程 喆, 等. 肝动脉化疗栓塞联合射频消融治疗中晚期肝癌的临床疗效分析[J]. 放射学实践, 2010, 25: 799- 802.
[3] Miyayama S, Matsui O, Taki K, et al. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization[J]. Cardiovasc Intervent Radiol, 2006, 29: 39- 48.
[4] 李金鹏, 陈 华, 石丛丛, 等. TACE联合射频消融与单独射频消融治疗结节型肝癌临床对比分析[J]. 临床放射学杂志,2013, 32: 1159- 1163.
[5] Kelogrigoris M, Laspas F, Kyrkou K, et al. Percutaneous radiofrequency ablation for malignant liver tumours in challenging locations[J]. J Med Imaging Radiat Oncol, 2012, 56: 48- 54.
[6] 陈长广, 倪才方, 陈 珑. 肝动脉栓塞联合射频消融对兔肝癌模型细胞凋亡的影响[J]. 实用放射学杂志, 2014, 30: 156- 159.
[7] Garmi L, Georgiades C. Combination percutaneous and intra-arterial therapy for the treatment of hepatocellular carcinoma: a review[J]. Semin Intervent Radiol, 2010, 27: 296- 301.
[8] 吴宇旋, 窦永充, 张彦舫, 等. 经皮射频消融治疗巨大肝癌[J]. 介入放射学杂志, 2007, 16: 755- 758.
[9] 帕哈尔丁?白克热, 杨树法, 黄伍奎, 等. 肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价[J]. 介入放射学杂志, 2012, 21: 322- 326.
[10] 彭国文, 李晓群. 射频消融及组合方案治疗特殊/高危部位肝癌的中远期疗效[J]. 介入放射学杂志, 2013, 22: 525- 528.

相似文献/References:

[1]程洁敏,王建华.喜树碱微球化疗栓塞治疗原发性肝癌10例报告[J].介入放射学杂志,1993,(01):47.
[2]卢丽琴,陈方宏,袁建华,等.晚期肝癌伴门脉癌栓的介入治疗[J].介入放射学杂志,1996,(03):136.
[3]张   磊,陆骊工,李   勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
 ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(08):968.
[4]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
 AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(08):1010.
[5]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
 DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(08):75.
[6]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
 ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(08):78.
[7]姚红响,陈根生,诸葛英,等.肝动脉化疗栓塞联合CT引导射频消融序贯治疗中小肝癌的临床应用[J].介入放射学杂志,2012,(04):301.
 ,,et al.Sequential treatment with TACE and CTguided RFA for small and moderate sized HCC [J].journal interventional radiology,2012,(08):301.
[8]赵许亚,周 石.TACE联合经皮瘤内注射碘油吡柔比星乳剂治疗中晚期肝癌疗效分析[J].介入放射学杂志,2012,(08):675.
 ZHAO Xu- ya,ZHOU Shi.. Transcatheter artery chemoembolization combined with percutaneous intratumoral injection of Lipiodol emulsion of pirarubicin for advanced hepatocellular carcinomas: an analysis of clinical efficacy[J].journal interventional radiology,2012,(08):675.
[9]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
 HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(08):682.
[10]冉 琳,任伯绪. 125I粒子组织间近距离放射治疗肝癌的现状与进展[J].介入放射学杂志,2012,(10):876.
 RAN Lin,REN Bo- xu.. 125I radioactive seeds brachytherapy for hepatocellular carcinomas: its present situation and research progress[J].journal interventional radiology,2012,(08):876.
[11]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
 ,,et al.TACE combined with radiofrequency ablation for massive primary hepatocellular carcinomas: a clinical therapeutic evaluation [J].journal interventional radiology,2012,(08):322.
[12]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
 .The volume of Lipiodol used in TACE: its current situation and research progress [J].journal interventional radiology,2012,(08):348.
[13]薛幼华,芮冶昊,黄薛菲,等.快速康复理念在肝癌患者行肝动脉化疗栓塞中的应用[J].介入放射学杂志,2016,(01):78.
 XUE You- hua,RUI Ye- hao,HUANG Xue- fei,et al.The application of fast recovery concept in treating patients with liver cancer by using transcatheter arterial chemoembolization[J].journal interventional radiology,2016,(08):78.
[14]施昌盛,杨 庆,肖池金,等.血清高迁移率组蛋白B1、可溶性晚期糖基化终末产物受体、脱氧核糖核酸酶与TACE早期疗效相关性研究[J].介入放射学杂志,2016,(08):677.
 SHI Chang-sheng,YANG Qing,XIAO Chi-jin,et al.Correlation study between HMGB1, sRAGE, DNase and the short-term efficacy of TACE [J].journal interventional radiology,2016,(08):677.
[15]蒋力平,刘兵元,张立鹏.乙肝相关肝癌患者行TACE术后HBV再激活的临床研究 [J].介入放射学杂志,2018,27(02):171.
 JIANG Liping,LIU Bingyuan,ZHANG Lipeng.Clinical study of hepatitis B virus reactivation in patients with hepatitis B- related liver cancer after receiving transcatheter arterial chemoembolization therapy[J].journal interventional radiology,2018,27(08):171.
[16]周旭林,满沐苒,王璐璐,等.肝动脉化疗栓塞联合放疗治疗中晚期肝癌疗效与安全性的荟萃分析 [J].介入放射学杂志,2019,28(05):428.
 ZHOU Xulin,MAN Muran,WANG Lulu,et al.TACE combined with radiotherapy for the treatment of mid- stage and advanced liver cancers: a meta- analysis of its clinical efficacy and safety[J].journal interventional radiology,2019,28(08):428.

备注/Memo

备注/Memo:
(收稿日期:2014-11-27)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2015-08-23